Michael Scolaro

Michael Scolaro

Aug 22, 2017

Group 6 Copy 22
0
    Please wait...

    About This Project

    We hypothesize that targeted delivery of Curcumin to antigen presenting cells in the immune system can suppress tumor growth for a variety of cancers. This study will examine tumor responses to Curcumin in a colon cancer mouse model when given alone or in combination with an FDA-approved immune Checkpoint Inhibitor. Positive results will lead to Fast-Track FDA applications for human and companion pet animal cancer trials.

    Blast off!

    Browse Other Projects on Experiment

    Related Projects

    Open Insulin

    A team of biohackers is developing the first open source protocol to produce insulin simply and economically...

    How to edit any gene.

    Imagine being able to edit any geneā€”from Alzheimer's and cancer to eye color and balding. Today, that is almost...

    Can we stop the spread of breast cancer?

    Cancer treatment is a challenging, complex and exhausting process for the patient, their family and medical...

    Backer Badge Funded